Back to WELLINGTON MANAGEMENT GROUP LLP

CRNX
Showing 8 of 14 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLP's holdings in CRINETICS PHARMACEUTICALS IN

WELLINGTON MANAGEMENT GROUP LLP holds 8.2M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $296.3M as of 2026-Q1. The position was increased (+1.5% shares). CRNX represents 0.1% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$296.3M

Current Shares

8.2M

Total Value Change

+$89.3M

Total Shares Change

+3.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
8.2M
+1.5%
$296.3M0.1%$40.12
31
2025-Q4
Decreased
8M
-4.1%
$374.2M0.1%$47.39
0
2025-Q3
Increased
8.4M
+44.3%
$349.1M0.1%$43.51
42
2025-Q2
Decreased
5.8M
-15.7%
$167M0.0%$29.96
0
2025-Q1
Decreased
6.9M
-0.8%
$231.1M0.0%$34.73
0
2024-Q4
Increased
7M
+55.9%
$355.4M0.1%$50.67
44
2024-Q3
Decreased
4.5M
-3.5%
$227.9M0.0%$50.75
0
2024-Q2
Increased
4.6M
+55.5%
$206.9M0.0%$44.79
43

Other major holders of CRNX: FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used